MMP-9 is highly expressed in a variety of tumor tissues, including gastric cancer, breast cancer, prostate cancer, osteosarcoma, and non-small-cell lung cancer, and is correlated with clinical classification, lymph node metastasis, and overall survival rates [4–8]. This evidence concerns the gene MMP9 and neoplasm.